Arrowstreet Capital’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-51,863	Closed	-$678K	–	1509
2022 Q3	$678K	Buy	51,863 +37,880	+271%	+$495K	﹤0.01%	1054
2022 Q2	$179K	Buy	+13,983	New	+$179K	﹤0.01%	1172
2020 Q3	–	Sell	-81,016	Closed	-$1.6M	–	2576
2020 Q2	$1.6M	Buy	+81,016	New	+$1.6M	﹤0.01%	1574